In patients with congestive heart failure (CHF), the poor relationship between systemic exercise performance and cardiac function, together with morphologic and metabolic abnormalities in skeletal muscle, raises the possibility that skeletal muscle function may be impaired and limit systemic exercise performance. We assessed strength and endurance of the knee extensors during static and dynamic exercise in 16 patients with Class I-IV CHF and eight age-matched sedentary controls and related these measurements to systemic exercise performance. To assess skeletal muscle function independent of peripheral blood flow, endurance was repeated under ischemic conditions. Strength was not significantly different in the two groups. Dynamic endurance, quantified as the decline in peak torque during 15 successive isokinetic knee extensions, was significantly reduced in the patients compared to controls during aerobic (peak torque 65 vs. 86% of initial for exercise at 90 deg/s and 60 vs. 85% for exercise at 180 deg/s; P < 0.002 for both), and during ischemic exercise (56 vs. 76% of initial torque; P < 0.01). Static endurance, defined as the time required for force during a sustained maximal voluntary contraction to decline to 60% of maximal, was reduced in the patients compared to controls (40±14 vs. 77±29 s; P < 0.02). There were highly significant relationships between systemic exercise performance and skeletal muscle endurance at 90 and 180 deg/s in the patients with CHF (r = 0.90 and 0.66, respectively). These findings indicate that skeletal muscle endurance is impaired in patients with CHF, that this abnormality is in part independent of limb blood flow, and that these changes may be important determinants of systemic exercise performance. (J. Clin. Invest. 1991.
Introduction
Maximal cardiac output limits systemic exercise performance in healthy subjects (1) (2) (3) . However, in patients with congestive heart failure (CHF),' the mechanism limiting systemic exercise performance is unknown. In CHF patients it is commonly observed that systemic exercise performance correlates poorly with cardiac output, ejection fraction, and left atrial pressures both at rest and during exercise (4) (5) (6) (7) . The discordance between systemic exercise performance and cardiac function in CHF patients is further demonstrated by the temporal dissociation between the rapid improvement in hemodynamics (within hours after initiating medical treatment) and the gradual improvement in systemic exercise performance (weeks to months after initiating medical treatment) (8, 9) . These observations suggest that systemic exercise performance in CHF patients, unlike that in healthy subjects, is not limited solely by central hemodynamics.
A possible factor determining exercise performance in CHF patients may be impaired skeletal muscle function. Recent work has demonstrated that patients with CHF have abnormalities in skeletal muscle histology and biochemistry (10) , and that during exercise their peripheral blood flow (1 1), and skeletal muscle metabolism (12, 13) are abnormal. It is unknown, however, whether skeletal muscle function in CHF patients is impaired, and if so whether impaired function is independent ofabnormalities ofblood flow. Also, the relationship ofskeletal muscle function to systemic exercise performance has not been determined.
The goals of this study were threefold: first, to determine whether skeletal muscle function is abnormal in patients with CHF; second, to determine whether impaired function, ifpresent, is independent of blood flow; and third, to determine whether impaired skeletal muscle function in CHF patients may be responsible for their exercise limitation.
To measure skeletal muscle function we localized exercise to the knee extensor muscle group, and assessed both strength and endurance during static and isokinetic exercise in CHF patients and age-matched sedentary controls. To determine if impaired endurance is independent ofblood flow, we exercised the knee extensor muscles under ischemic conditions and compared muscle endurance in these two groups. To ascertain if skeletal muscle dysfunction could limit systemic exercise performance, we determined the relationship ofknee extensor endurance (skeletal muscle function) to peak systemic oxygen consumption (systemic exercise performance).
Methods
Patient population (Table I) 16 male subjects with a history of Class I-IV chronic CHF ofat least 6 mo in duration were recruited from the Veterans Affairs Medical Center in San Francisco. Salient clinical information concerning these patients is given in Table I . The diagnosis of CHF was based on a history of dyspnea on exertion, fatigue, or fluid retention, with confirmation ofleft ventricular dysfunction by a radionuclide or echocardiographic ejection fraction of < 40% (range 7-37%). Eight patients had ischemic cardiomyopathy, and eight had primary myocardial disease. Patients were excluded if they had experienced myocardial infarction Angle (deg) Figure 1 . Characteristic torque vs. angle loops for each isokinetic knee extension in a patient with CHF. Each knee extension demonstrates similar initial rates of torque production and similar angles at which maximal torque production was achieved. The consistency of these torque vs. angle loops cannot be achieved with submaximal effort. Exercise protocols Isokinetic exercise. Dynamic strength and endurance of the knee extensors were measured on an isokinetic dynamometer (340; Cybex, Ronkonkoma, NY), which consists of a fixed length lever arm with its range of motion mechanically limited. The resistance of the lever arm is automatically adjusted in proportion to the dynamic tension produced by the muscle throughout the entire range of motion. This device continuously records torque during isokinetic muscle contraction at a selected angular velocity. Unlike isometric or isotonic muscle testing, the controlled variable during isokinetic contraction is the velocity of the muscle contraction and not the applied resistance.
The subject was stabilized on the adjustable dynamometer testing table. To prevent hip and upper body movement, the backrest was positioned at a 15-deg incline, and a seatbelt and shoulder strap were used to anchor the subject to the backrest. The subject's right knee was then aligned with the input axis of the lever arm, and the ankle was attached to the distal end of the lever arm. After familiarization with the dynamometer, and a standardized warm-up period, each subject was tested at two predetermined velocities (90 and 180 deg/s) in random order. The exercise protocol consisted of extending the knee 15 times in rapid succession at each velocity. Each knee extension lasted for -2-s. The subjects rested for 10-min before exercise at the second velocity. Throughout the procedure, verbal encouragement was given in a standardized manner.
Torque vs. angle ( Fig. 1 ) loops were recorded for each knee extension, to allow determination of the reproducibility of effort. A characteristic record ofthe torque output during 15 isokinetic knee extensions is shown in Fig. 2 . Continuous knee extension resulted in a progressive decrease in torque production throughout exercise in the CHFpatients. Dynamic strength was quantified as the mean peak torque produced in the first three knee extensions. Dynamic endurance was defined as the ratio of the mean peak torque in the last three repetitions as compared to the first three repetitions (14, 15 while the decline of force was recorded over time. Subjects continued to contract maximally until isometric force declined to 60% ofthe initial maximal force. Static endurance time was defined as the time required for isometric force to decline to 60% of maximal. Systemic exercise performance. On a separate occasion, systemic exercise was performed using an electronically braked cycle ergometer (Quinton Instruments, Seattle, WA) that maintained constant workload at pedal frequencies of40-1 10 rpm. Testing was performed in an air conditioned laboratory with an ambient temperature of 22-240C and humidity of30-40%. Before exercise, subjects rested upright on the cycle ergometer for 5 min. Exercise was initially performed unloaded for 2 min. The load was then increased to 200 kg-m/min (kpm) for 2 min, and then by 100 kpm every 2 min until exhaustion. Exhaustion was defined as the inability to maintain a pedal frequency of> 40 rpm. Standard verbal encouragement was used for all subjects.
Peak oxygen consumption was measured as an index of systemic exercise performance, and the respiratory quotient was measured to quantify exercise effort. For these measurements, expired gases were collected into a mixing chamber through a mouthpiece and V02 and VCO2 were measured at 15-s intervals throughout exercise using a metabolic cart (Sensor Medics Corp., Anaheim, CA). Peak systemic oxygen consumption was defined as the highest oxygen consumption reached during exercise.
Statistical methods
Differences in muscle endurance, muscle strength, and in peak oxygen consumption between the CHF patients and controls were analyzed by Student's t test for unpaired samples. Linear regression was used to examine the relationships of endurance ofthe knee extensors with left ventricular ejection fraction and peak systemic oxygen consumption. Statistical significance was assumed for P values < 0.05 (16) . Values are reported as the mean±one standard deviation.
Results
Isometric exercise measurements. Static strength was somewhat, but not significantly lower in the CHF patients than in the normal subjects (89±27 ft-lb vs. 102±18 ft-lb, P < 0.15). However, the CHF patients fatigued far more rapidly, as indicated by the shorter static endurance time in the 12 patients in whom it was measured (40±14 vs. 77±29 s, P < 0.002) (Fig. 3) .
Isokinetic exercise measurements. Examination of the torque-angle loops (Fig. 1) confirmed that in each subject serial repetitions were performed with a similar initial torque output and achieved peak torque at a similar angle. This degree of reproducibility is consistent with maximum effort. As can be seen from the patient example in Fig. 2, peak Figure 4 . This plot shows the values for peak torque in the initial and final three repetitions in the CHF patients (n = 16) and controls (n = 8). At the slower exercise velocity, peak torque declined to 65% of the initial value in the patients with CHF, which is greater (P < 0.002) than the peak torque decline to 86% of the initial value in the controls. At the faster exercise velocity, peak torque declined to 60% of the initial value in the patients with CHF, which is greater (P < 0.001) than the decline ofpeak torque to 85% ofthe initial value in the controls.
deg/s (68±22 vs. 85±27 ft-lb, P = 0.12), and at 180 deg/s (46±16 vs. 56±13 ft-lb, P = 0.15) (Fig. 4 ), but these differences did not reach statistical significance. Dynamic endurance, defined as the ratio ofmean torque in the last three isokinetic knee extensions compared to the first three extensions, was reduced in CHF group compared to the control subjects at both exercise velocities. At 90 deg/s, peak torque in the CHF patients declined to 65% ofthe initial value (from 68±22 to 46±19 ft-lb), which was more (P < 0.002) than the decline in peak torque to 86% of the initial value in the controls (from 85±27 to 73±22 ft-lb). The decline in peak torque occurred immediately in the CHF patients, falling to 81% of its initial value after five repetitions, as compared to 97% in the controls (P < 0.01).
The results at the 180 deg/s velocity were similar to those at 90 deg/s. Peak torque in the CHF patients declined to 60% of the initial value (from 47±16 to 29±12 ft-lb), which was more (P < 0.001) than the decline in peak torque to 85% ofthe initial value in the controls (from 56±13 to 47±11 ft-lb). Within each group, peak torque declined to similar degrees at the two veloci- . This plot shows the values for peak torque in the initial and final three repetitions in the CHF patients (n = 7) and controls (n = 7) during ischemic exercise at the 90 deg/s velocity. Peak torque declined to 56% of the initial value in the patients with CHF, which is greater (P < 0.01) than the peak torque decline to 76% ofthe initial value in the controls. There is a strong correlation between dynamic endurance and peak systemic oxygen consumption (r = 0.90, P < 0.001).
Furthermore, there was no apparent relationship between left ventricular ejection fraction and peak systemic V02 (Fig. 7) .
Heart rate responses during exercise. In the CHF patients during the more strenuous isokinetic protocol at the 90 deg/s velocity, heart rate rose modestly, by a mean of 13 bpm, from 86±14 to 99±15. The small magnitude ofthese changes is consistent with the limited muscle mass exercised and with a relatively small cardiovascular stress. The heart rate changes were of lesser magnitude at the 180 deg/s velocity, from 86±14 to 96±12 bpm. During cycle ergometry, heart rate rose to 143±19 bpm. Discussion ties (to 65±13 and 60±13% in the CHF patients, P = NS, and to 86±12 and 85±10% in the controls, P = NS) (Fig. 4) .
Ischemic isokinetic exercise measurements. During ischemic exercise at 90 deg/s, dynamic endurance was also reduced; peak torque declined further in the patients with CHF than in the controls. Mean peak torque declined in the CHF patients to 56% of the initial value (from 75±21 to 44±20), which was more (P < 0.01) than the decline in mean peak torque to 76% of the initial value in the controls (from 82±14 to 62±16) (Fig. 5) .
Relationship ofmuscle endurance to systemic exercise performance. Mean peak systemic oxygen consumption was lower in the CHF patients than in the controls (16±5 vs. 27±8 ml OJkg/min, P < 0.05). The relatively low value in the controls confirms their sedentary life style (1), and the range from 8 to 27 ml OJKg/min in the CHF patients is consistent with a wide range of functional capacity. Peak oxygen consumption correlated significantly with dynamic endurance as measured at both velocities in the CHF patients. The correlation was stronger for endurance at 90 deg/ s, which is shown in Fig. 6 (r = 0.90, P < 0.001), than for endurance at 180 deg/s (r = 0.66, P = 0.005). In the control subjects, the correlation between peak oxygen consumption and dynamic endurance was poor both at 90 deg/s (r = 0.37, P = NS) and at 180 deg/s (r = 0.43, P = NS). In both the patients with CHF and the controls no significant correlations were found for the relationships of peak systemic oxygen consumption vs. either static strength, endurance, or dynamic strength. Ejection Fraction Figure 7 . This plot depicts the individual values of peak systemic oxygen consumption and ejection fraction in the CHF patients (n = 16).
There was no significant correlation between these measurements (r = 0.20).
Exercise intolerance is a frequent symptom in patients with congestive heart failure. Although these patients have impaired cardiac function and hemodynamics, the degree ofcardiac dysfunction correlates poorly with their ability to perform systemic exercise. Recent studies have shown morphologic and metabolic abnormalities of skeletal muscle in these patients, suggesting that these changes might result in functional abnormalities in skeletal muscle, and therefore be important in limiting exercise tolerance. In this study, we examined several indices ofskeletal muscle function and determined the relationship between muscle function and systemic exercise capacity. The major finding ofthis study is that skeletal muscle function is abnormal in CHF. Although muscle strength was relatively preserved, endurance during both static and dynamic exercise was markedly diminished when compared to sedentary age-matched controls. Potential causes for reduced muscle endurance include diminished blood flow to exercising muscle, submaximal effort, and structural or biochemical changes in skeletal muscle.
Zelis and co-workers first described attenuated blood flow responses during forearm exercise and after forearm ischemia in patients with CHF (1 1). Although other investigators found no reduction of forearm blood flow in CHF patients who had less fluid retention or lower central venous pressures ( 12, 17) , blood flow impairment has been a consistent finding during exercise protocols which provide greater cardiovascular stress and involve larger muscles (18, 19) . The reduction of peripheral blood flow have been ascribed both to inadequate perfusion pressure and to impaired peripheral vasodilation (1 1) .
The knee extension protocol employed in this study involves a larger muscle group than that exercised in forearm studies, but the relatively brief exercise duration and modest associated hemodynamic changes suggest that muscle performance during this protocol was not limited by cardiac reserve. Indeed, the very rapid decline in peak torque, which achieved statistical significance relative to the controls by the fifth repetition, also supports the hypothesis that an impaired cardiac output response is not the only factor limiting exercise.
To determine definitively whether reduced cardiac output or abnormal muscle blood flow were solely responsible for the diminished muscle endurance, the isokinetic exercise protocol was repeated under ischemic conditions. The finding that abnormal endurance was present during suprasystolic thigh cuff occlusion demonstrates skeletal muscle dysfunction in CHF patients is not due solely to changes in blood flow to exercising muscle. This conclusion is also supported by the briefer endurance time found in the patients during prolonged static exercise, because blood flow to muscle is obstructed during maximal sustained isometric contraction at the levels employed in this protocol (20) . Whereas these results indicate factors other than inadequate cardiac output and peripheral blood flow are involved in muscle endurance, they do not exclude a role for abnormalities in resting or exercise blood flow in the evolution of muscle dysfunction.
Thus, the reduced muscle endurance in the CHF patients most likely reflects, at least in part, a structural or metabolic defect in skeletal muscle. Muscle atrophy has been demonstrated in patients with CHF (21) and could play a role in the reduced endurance. However, in preliminary studies by other workers, the degree of atrophy has not correlated well with either exercise capacity or muscle metabolism (22) . Also, atrophy is not likely to fully explain the alterations in muscle function observed in the present study, because the changes in endurance were greater than those in muscle strength and the latter usually reflects muscle mass. Furthermore, endurance was quantified relative to the initial torque values, so that generalized muscle atrophy should not have been a major determinant of endurance.
Our findings contrast with the results of Lipkin et al. (10), who found lower maximal static strength in the quadriceps femoris muscle in eight patients with severe CHF than in controls. This difference may result from the wider range of clinical symptoms and exercise capacity in our patients than in the group examined by Lipkin et al. or from their use of more active control subjects. Their patients may have had more muscle atrophy, which would be expected to be associated with reduced strength.
The impaired muscle endurance is consistent with the metabolic changes commonly observed in exercising skeletal muscle in patients with CHF. A rapid accumulation of metabolic byproducts in exercising muscle ofCHF patients could be responsible for the decline in muscle contractile force. For example, muscular fatigue has been attributed to intracellular lactate accumulation (23), acidosis, or the increased concentration of inorganic phosphate or its diproteinated form (H2PO4) (24) (25) (26) . Metabolic studies employing magnetic resonance spectroscopy have revealed abnormalities of muscle metabolism in CHF patients (12, 17) . These studies demonstrated a lower intracellular pH and faster accumulation of both inorganic phosphate and H2PO4 at similar workloads in CHF patients compared to healthy controls, which might then explain the observed reduction in endurance.
Although submaximal effort in these patients cannot be totally excluded as a reason for the decreased muscle endurance, this explanation is unlikely. The torque vs. angle loops recorded during the serial knee extensions demonstrate similar initial rates of torque production and similar angles at which maximal torque was achieved. This consistency of performance cannot be accomplished with submaximal effort. In addition, changes in central command cannot be excluded as a potential cause for the difference in endurance time during static exercise between the groups.
The potential importance ofskeletal muscle dysfunction in CHF patients is demonstrated by the significant correlations between isokinetic endurance at both the 90 and 180 deg/s velocities and peak systemic V02. This suggests that peripheral skeletal muscle dysfunction might be an important determinant ofexercise performance and fatigue. This relationship was particularly close at the slower velocity, which provides a greater resistance and thus involves a greater proportion of both oxidative and glycolytic fibers. The lack of correlation between static endurance and peak V02 is not surprising, because static, anaerobic exercise is physiologically very different from dynamic aerobic exercise during cycle ergometry.
The strong correlation between muscle function and systemic exercise performance is particularly significant in view of the weak correlation between cardiac function and peak V02 observed in the present study and many previous investigations (4) (5) (6) (7) . This disparity between central hemodynamics and exercise performance suggests that impaired muscle endurance is an important determinant of systemic exercise in patients with CHF.
In summary, the major findings ofthis study are that CHF patients have impaired muscle endurance, which is, in part independent of muscle blood flow. Also, the muscle dysfunction in CHF may have a major role in limiting systemic exercise performance. These results are consistent with the findings that an exercise regimen which stimulates training adaptations in skeletal muscle, is effective in increasing exercise performance in patients with CHF without altering cardiac function or exercise blood flow (19, 27) and, conversely, they are consistent with the observation that treatments which rapidly improve central hemodynamics are not paralleled by rapid increases in systemic exercise performance (9) .
